About Early Cure Pharmacy Private Limited
Data last updated:
Early Cure Pharmacy Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2011PTC229074. Its GSTIN is 07AACCE9722G1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Relief Retails Prvate Limited. It is led by directors including Sangita Devi and Harishchandra Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 113 & 114 First Floor Plot No 1 Lsc Gazipur Patparganj, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.19 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹82,304 (net margin 0.7%) and EBITDA of ₹2.26 Lakh (EBITDA margin 1.9%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 11% over five years.
The company is associated with 1 brand: Medjio.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medjio.com.
Company details
Contact details
Early Cure Pharmacy Private Limited's registered office is in New Delhi, Delhi. Its website is medjio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No 113 & 114 First Floor Plot No 1 Lsc Gazipur Patparganj, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Early Cure Pharmacy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Early Cure Pharmacy operates one associated brand: Medjio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Functions as an online pharmacy store for convenient medicine purchases. | medjio.com |
Business activity
The main business activity of Early Cure Pharmacy is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Early Cure Pharmacy Private Limited, buy the company report.
Financials of Early Cure Pharmacy Private Limited
FY 2025 filings availableEarly Cure Pharmacy Private Limited reported revenue of ₹1.19 Cr (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹82,304 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Early Cure Pharmacy Private Limited, buy the company report.
Board of directors of Early Cure Pharmacy Private Limited
Early Cure Pharmacy has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangita Devi | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
| Harishchandra Kumar | Director | 27 Dec 2021 | 4 Years 10 Months | Current |
| Neeraj Garg | Director | 31 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Early Cure Pharmacy Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uparjan Trading Private Limited | ₹1.19 Cr (FY 2024) | New Delhi, Delhi, India | ||||
| Maninfini Trends Private Limited | ₹1.19 Cr (FY 2025) | 278.0% | Bangalore, Karnataka, India | |||
| Bhor Software Private Limited | ₹1.19 Cr (FY 2025) | 9.0% | Navi Mumbai, Maharashtra, India | |||
| Shakti Zarda Factory (India) Private Limited | ₹1.19 Cr (FY 2025) | 153.0% | Delhi, India | |||
| Sra Enterprises Private Limited | ₹1.19 Cr (FY 2025) | -33.0% | New Delhi, Delhi, India | |||
| Early Cure Pharmacy Private Limitedthis company | ₹1.19 Cr (FY 2024) | ₹82,304 | 0.7% | 9.0% | New Delhi, Delhi, India | |
| VSS Air Solutions Private Limited | ₹1.19 Cr (FY 2023) | 747.0% | Hyderabad, Telangana, India | |||
| DW Bazar 365 Superstore Private Limited | ₹1.19 Cr (FY 2019) | 240.0% | New Delhi, Delhi, India | |||
| Octance Healthcare Private Limited | ₹1.19 Cr (FY 2024) | 582.0% | Mumbai, Maharashtra, India | |||
| Savage Ecology Foundation | ₹1.19 Cr (FY 2025) | -40.0% | Surendranagar, Gujarat, India | |||
| Livraison Food Products Private Limited | ₹1.19 Cr (FY 2019) | 43.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Early Cure Pharmacy Private Limited, buy the company report.
Shareholding
The shareholding of Early Cure Pharmacy Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Early Cure Pharmacy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Early Cure Pharmacy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Early Cure Pharmacy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Early Cure Pharmacy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCE9722G1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Early Cure Pharmacy Private Limited, buy the company report.
Recent activity
Early Cure Pharmacy Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Neeraj Garg ceased to be Director on 21 Mar 2022.
Frequently asked questions
Early Cure Pharmacy is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 December 2011 (15+ years old) and is registered under CIN U52100DL2011PTC229074.
Early Cure Pharmacy has 3 current directors:
- Sangita Devi - Director
- Harishchandra Kumar - Director
- Neeraj Garg - Director
The latest financial statements of Early Cure Pharmacy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Early Cure Pharmacy is 07AACCE9722G1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Early Cure Pharmacy is U52100DL2011PTC229074. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Early Cure Pharmacy was incorporated on 21 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Early Cure Pharmacy by revenue are Uparjan Trading Private Limited, Maninfini Trends Private Limited, Bhor Software Private Limited, Shakti Zarda Factory (India) Private Limited, Sra Enterprises Private Limited and 5 more, all in the same principal business activity (retail trading).
Neeraj Garg ceased to be Director on 21 Mar 2022. Harishchandra Kumar was appointed as Director on 27 Dec 2021. Sangita Devi was appointed as Director on 27 Dec 2021. Early Cure Pharmacy has 7 board changes on record in total.
Early Cure Pharmacy can be reached through the website medjio.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Early Cure Pharmacy is at Shop No 113 & 114 First Floor Plot No 1 Lsc Gazipur Patparganj, New Delhi, Delhi, India – 110092.
Early Cure Pharmacy operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
